IBDEI0EP ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6719,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,6719,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,6719,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,6720,0)
 ;;=464.00^^31^413^2
 ;;^UTILITY(U,$J,358.3,6720,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6720,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,6720,1,5,0)
 ;;=5^Acute Laryngitis
 ;;^UTILITY(U,$J,358.3,6720,2)
 ;;=Acute Laryngitis^323469
 ;;^UTILITY(U,$J,358.3,6721,0)
 ;;=790.6^^31^413^1
 ;;^UTILITY(U,$J,358.3,6721,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6721,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,6721,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,6721,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,6722,0)
 ;;=780.60^^31^413^20
 ;;^UTILITY(U,$J,358.3,6722,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6722,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,6722,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,6722,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,6723,0)
 ;;=795.51^^31^413^55
 ;;^UTILITY(U,$J,358.3,6723,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6723,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,6723,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,6723,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,6724,0)
 ;;=070.9^^31^413^35
 ;;^UTILITY(U,$J,358.3,6724,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6724,1,4,0)
 ;;=4^070.9
 ;;^UTILITY(U,$J,358.3,6724,1,5,0)
 ;;=5^Hepatitis,Viral NOS
 ;;^UTILITY(U,$J,358.3,6724,2)
 ;;=^266636
 ;;^UTILITY(U,$J,358.3,6725,0)
 ;;=V12.09^^31^413^26
 ;;^UTILITY(U,$J,358.3,6725,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6725,1,4,0)
 ;;=4^V12.09
 ;;^UTILITY(U,$J,358.3,6725,1,5,0)
 ;;=5^HX of Infectious Disease
 ;;^UTILITY(U,$J,358.3,6725,2)
 ;;=^303396
 ;;^UTILITY(U,$J,358.3,6726,0)
 ;;=088.81^^31^413^44
 ;;^UTILITY(U,$J,358.3,6726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6726,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,6726,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,6726,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,6727,0)
 ;;=368.8^^31^413^79
 ;;^UTILITY(U,$J,358.3,6727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6727,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,6727,1,5,0)
 ;;=5^Vision Change/Blurring/Visual Dist
 ;;^UTILITY(U,$J,358.3,6727,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,6728,0)
 ;;=682.0^^31^414^6
 ;;^UTILITY(U,$J,358.3,6728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6728,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,6728,1,5,0)
 ;;=5^Cellulitis Of Face
 ;;^UTILITY(U,$J,358.3,6728,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,6729,0)
 ;;=681.00^^31^414^7
 ;;^UTILITY(U,$J,358.3,6729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6729,1,4,0)
 ;;=4^681.00
 ;;^UTILITY(U,$J,358.3,6729,1,5,0)
 ;;=5^Cellulitis Of Finger Nos
 ;;^UTILITY(U,$J,358.3,6729,2)
 ;;=^271883
 ;;^UTILITY(U,$J,358.3,6730,0)
 ;;=682.7^^31^414^8
 ;;^UTILITY(U,$J,358.3,6730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6730,1,4,0)
 ;;=4^682.7
 ;;^UTILITY(U,$J,358.3,6730,1,5,0)
 ;;=5^Cellulitis Of Foot
 ;;^UTILITY(U,$J,358.3,6730,2)
 ;;=^271895
 ;;^UTILITY(U,$J,358.3,6731,0)
 ;;=682.4^^31^414^9
 ;;^UTILITY(U,$J,358.3,6731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6731,1,4,0)
 ;;=4^682.4
 ;;^UTILITY(U,$J,358.3,6731,1,5,0)
 ;;=5^Cellulitis Of Hand
 ;;^UTILITY(U,$J,358.3,6731,2)
 ;;=^271892
 ;;^UTILITY(U,$J,358.3,6732,0)
 ;;=682.6^^31^414^10
 ;;^UTILITY(U,$J,358.3,6732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6732,1,4,0)
 ;;=4^682.6
 ;;^UTILITY(U,$J,358.3,6732,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,6732,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,6733,0)
 ;;=682.1^^31^414^11
 ;;^UTILITY(U,$J,358.3,6733,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0EP
